What caused NUTX's EPS decline in 2023?

The decline in Nutex Health's EPS in 2023 can be attributed to several factors: 1. **Revenue Growth**: Despite the revenue growth, the company's EPS was negatively impacted by the increased expenses. For instance, in Q1 2023, the company's revenue increased by 807% year-over-year, reaching $53.2 million. However, this growth was not enough to offset the additional costs, resulting in a loss of $0.02 per share. 2. **Expansion and Investments**: Nutex Health plans to expand by four or five hospitals in 2023, which requires significant investments in infrastructure, equipment, and personnel. These expenses can temporarily strain the company's financial performance, leading to a decline in EPS. 3. **Insider Transactions**: The purchase of 50,000 shares by director John J. Waters at $0.469 per share, totaling $23,450, indicates confidence in the company's long-term prospects. However, such transactions do not directly impact the EPS but can influence investor sentiment. In summary, Nutex Health's EPS decline in 2023 was primarily caused by the company's expansion and investments, which led to increased expenses despite revenue growth.